APRETUDE (cabotegravir) is a prescription medicine used for HIV-1 PrEP to reduce the risk of getting HIV-1 infection in adults and adolescents who weigh at least 77 pounds (at least 35 kg).

APRETUDE is manufactured by GlaxoSmithKline.

Administration and Dosage:

APRETUDE is given every other month by a healthcare provider after initiation injections have been given 1 month apart for 2 consecutive months

Common Side Effects:

Pain, tenderness, hardened mass or lump, swelling, bruising, redness, itching, warmth, loss of sensation at the injection site, abscess, and discoloration; diarrhea; headache; fever; tiredness; sleep problems; nausea; dizziness; passing gas; stomach pain; vomiting; muscle pain; rash; loss of appetite; drowsiness; back pain; or upper respiratory infection

These are not all the possible side effects of APRETUDE. Call your healthcare provider for medical advice about side effects

More Information:

Please read the full Prescribing Information for ACTEMRA® and discuss any questions you have with your doctor.

Ready to Schedule an Appointment?

Please CLICK HERE to get started.


APRETUDE is indicated to treat:

  • HIV